The Pharmaceuticals Export Promotion Council of India (Pharmexcil) will hold its 11th annual general meeting (AGM) from September 22-24, 2015 at Hotel Trident in Hitech City in Hyderabad.

As part of this annual meet, the Council is planning to conduct 3 important events which include global pharma business meet, technical seminars and pharma CEOs conclave. According to Dr. P.V. Appaji, director general of Pharmexcil, as usual this year’s annual event is going to become a big platform for the Indian pharma fraternity to meet. “During the 11th annual meet we are inviting about 80 overseas buyers from important markets across the globe. The Indian players, particularly the SMEs can make this event an opportunity to meet pharmaceutical manufacturers and entrepreneurs to promote their products,” informed Appaji.

As the 11th AGM is going to witness finished formulations manufacturers, the Indian API exporters can use this platform to promote their APIs, pharma machinery and packaging equipments. As majority of Indian firms are also involved in contract manufacturing, they can also use the platform of 11th AGM as an opportunity to meet with global leaders to build up their business by participating in the B2B meetings.

“We are planning to conduct 4 sessions of B2B meetings along with an exhibition. We are also planning to conduct technical and commercial seminars, where the members can take part and share their views and upgrade their knowledge relating to recent regulations, exports and imports and can raise issues of their concern and suggest ideas,” said Appaji.

The technical seminars on pharma will focus on issues like regulatory compliances, clinical research, packaging solutions, PICS and its implications and harmonisation of Indian pharmacopeia in international markets. The seminar will also throw light on recent government schemes and issues relating to financing in pharmaceutical exports. Speakers are also expected to deliberate on issues concerning service providers for statutory compliance, export opportunities and intellectual property rights during the seminar.
 
During the CEOs conclave, which is scheduled to be held on September 23, all CEOs and leaders of Indian pharma industry are expected to attend and deliberate on present challenges facing the Indian pharma sector in the country. During the panel discussion, the leaders are expected to deliberate on preparedness of pharma industry to resolve the present issues and tackle the future challenges.

Senior government officials from the departments of commerce, pharmaceuticals, health, DCGI, DBT, DST, DGFT, state and central drug controllers are also expected to attend the 11th AGM event of the Pharmexcil.